Table 6.
Multivariate cox regression analysis for positive outcome in ADHF patients 90 d after discharge.
| Variables | HR | 95% CI | p Value |
|---|---|---|---|
| Body mass index, kg/m2 | 1.235 | 0.965–1.582 | 0.094 |
| Chronic kidney disease history | 1.710 | 0.452–6.460 | 0.429 |
| Anemia | 1.683 | 0.411–6.892 | 0.470 |
| Plasma BNP, pg/m | 1.001 | 1.000–1.002 | 0.008 |
| Plasma NT-proBNP, pg/mL | 1.000 | 1.000–1.000 | 0.942 |
| uNT-proBNP/uCr, pg/nmol | 0.998 | 0.997–1.000 | 0.045 |
| Plasma NGAL, ng/mL | 1.011 | 0.987–1.035 | 0.379 |
| Plasma PENK, pg/mL | 1.014 | 1.000–1.028 | 0.044 |
| LVEDD, mm | 1.235 | 0.965–1.582 | 0.096 |
| CRS-1 | 1.669 | 0.297–9.374 | 0.561 |
CRS-1: cardiorenal syndrome type 1; ADHF: acute decompensated heart failure; BNP: brain natriuretic peptide; NT-proBNP: N-terminal pro-brain natriuretic peptide; uNT-proBNP: urine N-terminal pro-brain natriuretic peptide; uCr: urine creatinine; PENK: proenkephalin; NGAL: neutrophil gelatinase-associated lipocalin; LVEDD: left ventricular end-diastolic diameter.